The Expression of PD-L1 in Different Molecular Subtypes of Triple-Negative Breast Cancer and Its Correlation with Prognosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Expression of PD-L1 in Different Molecular Subtypes of Triple-Negative Breast Cancer and Its Correlation with Prognosis

Published:2023 Issue:11 Volume:13 Page:17625-17631
ISSN:2161-8712
Container-title:Advances in Clinical Medicine
language:
Short-container-title:ACM

Author:

王晓玮

Publisher

Hans Publishers

Subject

General Engineering

Reference20 articles.

1. Programmed death-ligand 1 (PD-L1) expression predicts response to neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis

2. Ji, P., Gong, Y. and Hu, X. (2019) Role of PD-1/PD-L1 in Microenvironment of Breast Cancer. Chinese Journal of Oncology, 41, 401-405.

3. Consistent expression of PD-L1 in tumor microenvironment with peripheral PD-1/PD-L1 in circulating T lymphocytes of operable breast cancer: a diagnostic test

4. Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

5. The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3